Clinical Trial

MARPE-Associated Changes in Sleep and Airway

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 26, 2025 (before its estimated August 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
At the beginning of MARPE treatment (T1) and at the end of the 3-month consolidation phase (T2), patients will complete the teen-STOP-BANG questionnaire and the Pittsburgh Sleep Quality Index (PSQI) to assess the potential benefit of MARPE in reducing the risk of obstructive sleep apnea syndrome (OSAS). Additionally, changes in the upper airway will be evaluated using CBCT images obtained at T1 and T2.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-06-18.
Trial Details
NCT Number NCT07031349
Lead Sponsor Konya Necmettin Erbakan Üniversitesi
Conditions Rapid Maxillary Expansion
Enrollment 40 participants
Start Date 2025-05-30
Primary Completion 2025-08-30 (estimated)
Study Completion 2025-09-05 (estimated)
Updated on ClinicalTrials.gov 2025-06-26